VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q56233362 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000031.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q56233362‏
024 ‎‡a 0000-0002-8685-3252‏ ‎‡2 orcid‏
024 ‎‡a 7404424723‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q56233362‏
100 0 ‎‡a Paul H Anderson‏ ‎‡9 es‏ ‎‡9 sl‏ ‎‡9 ast‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a পল এইচ অ্যান্ডারসন‏ ‎‡9 bn‏
400 0 ‎‡a Paul H Anderson‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Paul H Anderson‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's 1,25-Dihydroxyvitamin D3 and extracellular calcium promote mineral deposition via NPP1 activity in a mature osteoblast cell line MLO-A5.‏
670 ‎‡a Author's 1α,25-dihydroxyvitamin D3 stimulates human SOST gene expression and sclerostin secretion‏
670 ‎‡a Author's 25-Hydroxyvitamin D requirement for maintaining skeletal health utilising a Sprague-Dawley rat model‏
670 ‎‡a Author's A Role for the Calcitonin Receptor to Limit Bone Loss During Lactation in Female Mice by Inhibiting Osteocytic Osteolysis.‏
670 ‎‡a Author's Adequate dietary vitamin D and calcium are both required to reduce bone turnover and increased bone mineral volume‏
670 ‎‡a Author's Analysis of vitamin D metabolism gene expression in human bone: evidence for autocrine control of bone remodelling‏
670 ‎‡a Author's Androgen Receptor Action in Osteoblasts in Male Mice Is Dependent on Their Stage of Maturation‏
670 ‎‡a Author's Bone CYP27B1 gene expression is increased with high dietary calcium and in mineralising osteoblasts.‏
670 ‎‡a Author's Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice‏
670 ‎‡a Author's Co-expression of CYP27B1 enzyme with the 1.5kb CYP27B1 promoter-luciferase transgene in the mouse‏
670 ‎‡a Author's Comparison of the biological effects of exogenous and endogenous 1,25-dihydroxyvitamin D3 on the mature osteoblast cell line MLO-A5.‏
670 ‎‡a Author's Determinants of circulating 1,25-dihydroxyvitamin D3 levels: the role of renal synthesis and catabolism of vitamin D.‏
670 ‎‡a Author's Discordant effects of vitamin D deficiency in trabecular and cortical bone architecture and strength in growing rodents.‏
670 ‎‡a Author's Early response of the human SOST gene to stimulation by 1α,25-dihydroxyvitamin D3.‏
670 ‎‡a Author's Efficacy and mechanisms of action of vitamin D in experimental polyarthritis.‏
670 ‎‡a Author's Evidence for altered osteoclastogenesis in splenocyte cultures from Cyp27b1 knockout mice‏
670 ‎‡a Author's Experimental evidence for the effects of calcium and vitamin D on bone: a review.‏
670 ‎‡a Author's Extracellular phosphate modulates the effect of 1α,25-dihydroxy vitamin D3 (1,25D) on osteocyte like cells‏
670 ‎‡a Author's Identification of growth factor independent-1 (GFI1) as a repressor of 25-hydroxyvitamin D 1-alpha hydroxylase (CYP27B1) gene expression in human prostate cancer cells‏
670 ‎‡a Author's Identification of vitamin D3 target genes in human breast cancer tissue.‏
670 ‎‡a Author's Mechanisms of vitamin D₃ metabolite repression of IgE-dependent mast cell activation‏
670 ‎‡a Author's Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3.‏
670 ‎‡a Author's Mineralization and bone resorption are regulated by the androgen receptor in male mice.‏
670 ‎‡a Author's Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels.‏
670 ‎‡a Author's Modulation of osteoclastic migration by metabolism of 25OH-vitamin D3.‏
670 ‎‡a Author's Novel targets of vitamin D activity in bone: action of the vitamin D receptor in osteoblasts, osteocytes and osteoclasts‏
670 ‎‡a Author's Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption‏
670 ‎‡a Author's Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase- polymerase chain reaction.‏
670 ‎‡a Author's Regulation of gene expression by the CYP27B1 promoter-study of a transgenic mouse model.‏
670 ‎‡a Author's Regulation of the 5'-flanking region of the human CYP27B1 gene in osteoblast cells.‏
670 ‎‡a Author's Response of the 5'-flanking region of the human 25-hydroxyvitamin D 1alpha-hydroxylase gene to physiological stimuli using a transgenic mouse model‏
670 ‎‡a Author's Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.‏
670 ‎‡a Author's Sex-related differences in the skeletal phenotype of aged vitamin D receptor global knockout mice‏
670 ‎‡a Author's Skeletal characterization of an osteoblast-specific vitamin D receptor transgenic (ObVDR-B6) mouse model.‏
670 ‎‡a Author's The effect of Vdr gene ablation on global gene expression in the mouse placenta.‏
670 ‎‡a Author's The local production of 1,25(OH)2D3 promotes osteoblast and osteocyte maturation‏
670 ‎‡a Author's The metabolism of 25-‏
670 ‎‡a Author's The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts.‏
670 ‎‡a Author's The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand‏
670 ‎‡a Author's The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation.‏
670 ‎‡a Author's The pleiotropic effects of vitamin D in bone‏
670 ‎‡a Author's The skeleton as an intracrine organ for vitamin D metabolism‏
670 ‎‡a Author's Vitamin D(3) signalling to mast cells: A new regulatory axis‏
670 ‎‡a Author's Vitamin D actions to regulate calcium and skeletal homeostasis‏
670 ‎‡a Author's Vitamin D activities and metabolic bone disease.‏
670 ‎‡a Author's Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model.‏
670 ‎‡a Author's Vitamin D levels in an Australian and New Zealand cohort and the association with pregnancy outcome.‏
670 ‎‡a Author's Vitamin D metabolism and biological activities‏
670 ‎‡a Author's Vitamin D metabolism within bone cells: effects on bone structure and strength‏
670 ‎‡a Author's Vitamin D Receptor Gene Ablation in the Conceptus Has Limited Effects on Placental Morphology, Function and Pregnancy Outcome‏
670 ‎‡a Author's Vitamin D receptor overexpression in osteoblasts and osteocytes prevents bone loss during vitamin D-deficiency.‏
909 ‎‡a (scopus) 7404424723‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000286853252‏ ‎‡9 1‏
919 ‎‡a comparisonofthebiologicaleffectsofexogenousandendogenous125dihydroxyvitamind3onthematureosteoblastcelllinemloa5‏ ‎‡A Comparison of the biological effects of exogenous and endogenous 1,25-dihydroxyvitamin D3 on the mature osteoblast cell line MLO-A5.‏ ‎‡9 1‏
919 ‎‡a vitamin500receptoroverexpressioninosteoblastsandosteocytespreventsbonelossduringvitamin500deficiency‏ ‎‡A Vitamin D receptor overexpression in osteoblasts and osteocytes prevents bone loss during vitamin D-deficiency.‏ ‎‡9 1‏
919 ‎‡a vitamin500receptorgeneablationintheconceptushaslimitedeffectsonplacentalmorphologyfunctionandpregnancyoutcome‏ ‎‡A Vitamin D Receptor Gene Ablation in the Conceptus Has Limited Effects on Placental Morphology, Function and Pregnancy Outcome‏ ‎‡9 1‏
919 ‎‡a vitamin500metabolismwithinbonecellseffectsonbonestructureandstrength‏ ‎‡A Vitamin D metabolism within bone cells: effects on bone structure and strength‏ ‎‡9 1‏
919 ‎‡a vitamin500metabolismandbiologicalactivities‏ ‎‡A Vitamin D metabolism and biological activities‏ ‎‡9 1‏
919 ‎‡a vitamin500levelsinanaustralianandnewzealandcohortandtheassociationwithpregnancyoutcome‏ ‎‡A Vitamin D levels in an Australian and New Zealand cohort and the association with pregnancy outcome.‏ ‎‡9 1‏
919 ‎‡a vitamin500depletioninducesranklmediatedosteoclastogenesisandbonelossinarodentmodel‏ ‎‡A Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model.‏ ‎‡9 1‏
919 ‎‡a vitamin500activitiesandmetabolicbonedisease‏ ‎‡A Vitamin D activities and metabolic bone disease.‏ ‎‡9 1‏
919 ‎‡a vitamin500actionstoregulatecalciumandskeletalhomeostasis‏ ‎‡A Vitamin D actions to regulate calcium and skeletal homeostasis‏ ‎‡9 1‏
919 ‎‡a vitamin5003signallingtomastcellsanewregulatoryaxis‏ ‎‡A Vitamin D(3) signalling to mast cells: A new regulatory axis‏ ‎‡9 1‏
919 ‎‡a skeletonasanintracrineorganforvitamin500metabolism‏ ‎‡A The skeleton as an intracrine organ for vitamin D metabolism‏ ‎‡9 1‏
919 ‎‡a pleiotropiceffectsofvitamin500inbone‏ ‎‡A The pleiotropic effects of vitamin D in bone‏ ‎‡9 1‏
919 ‎‡a pairedboxhomeodomaintranscriptionfactorpax6bindstotheupstreamregionofthetrapgenepromoterandsuppressesreceptoractivatorofnfκbligandranklinducedosteoclastdifferentiation‏ ‎‡A The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation.‏ ‎‡9 1‏
919 ‎‡a pairedboxhomeodomaintranscriptionfactorpax6bindstotheupstreamregionofthetrapgenepromoterandsuppressesreceptoractivatorofnfκbligand‏ ‎‡A The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand‏ ‎‡9 1‏
919 ‎‡a metabolismof255vitamind3byosteoclastsandtheirprecursorsregulatesthedifferentiationofosteoclasts‏ ‎‡A The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts.‏ ‎‡9 1‏
919 ‎‡a metabolismof25‏ ‎‡A The metabolism of 25-‏ ‎‡9 1‏
919 ‎‡a localproductionof12552d3promotesosteoblastandosteocytematuration‏ ‎‡A The local production of 1,25(OH)2D3 promotes osteoblast and osteocyte maturation‏ ‎‡9 1‏
919 ‎‡a effectofvdrgeneablationonglobalgeneexpressioninthemouseplacenta‏ ‎‡A The effect of Vdr gene ablation on global gene expression in the mouse placenta.‏ ‎‡9 1‏
919 ‎‡a skeletalcharacterizationofanosteoblastspecificvitamin500receptortransgenicobvdrb6mousemodel‏ ‎‡A Skeletal characterization of an osteoblast-specific vitamin D receptor transgenic (ObVDR-B6) mouse model.‏ ‎‡9 1‏
919 ‎‡a sexrelateddifferencesintheskeletalphenotypeofagedvitamin500receptorglobalknockoutmice‏ ‎‡A Sex-related differences in the skeletal phenotype of aged vitamin D receptor global knockout mice‏ ‎‡9 1‏
919 ‎‡a sclerostinregulatesreleaseofbonemineralbyosteocytesbyinductionofcarbonicanhydrase2‏ ‎‡A Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.‏ ‎‡9 1‏
919 ‎‡a responseofthe5flankingregionofthehuman25hydroxyvitamin5001alphahydroxylasegenetophysiologicalstimuliusingatransgenicmousemodel‏ ‎‡A Response of the 5'-flanking region of the human 25-hydroxyvitamin D 1alpha-hydroxylase gene to physiological stimuli using a transgenic mouse model‏ ‎‡9 1‏
919 ‎‡a regulationofthe5flankingregionofthehumancyp27b1geneinosteoblastcells‏ ‎‡A Regulation of the 5'-flanking region of the human CYP27B1 gene in osteoblast cells.‏ ‎‡9 1‏
919 ‎‡a regulationofgeneexpressionbythecyp27b1promoterstudyofatransgenicmousemodel‏ ‎‡A Regulation of gene expression by the CYP27B1 promoter-study of a transgenic mouse model.‏ ‎‡9 1‏
919 ‎‡a quantificationofmrnaforthevitamin500metabolizingenzymescyp27b1andcyp24andvitamin500receptorinkidneyusingrealtimereversetranscriptasepolymerasechainreaction‏ ‎‡A Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase- polymerase chain reaction.‏ ‎‡9 1‏
919 ‎‡a osteoclasticmetabolismof255vitamind3apotentialmechanismforoptimizationofboneresorption‏ ‎‡A Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption‏ ‎‡9 1‏
919 ‎‡a noveltargetsofvitamin500activityinboneactionofthevitamin500receptorinosteoblastsosteocytesandosteoclasts‏ ‎‡A Novel targets of vitamin D activity in bone: action of the vitamin D receptor in osteoblasts, osteocytes and osteoclasts‏ ‎‡9 1‏
919 ‎‡a modulationofosteoclasticmigrationbymetabolismof25ohvitamind3‏ ‎‡A Modulation of osteoclastic migration by metabolism of 25OH-vitamin D3.‏ ‎‡9 1‏
919 ‎‡a modulationofcyp27b1andcyp24mrnaexpressioninboneisindependentofcirculating12552d3levels‏ ‎‡A Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels.‏ ‎‡9 1‏
919 ‎‡a mineralizationandboneresorptionareregulatedbytheandrogenreceptorinmalemice‏ ‎‡A Mineralization and bone resorption are regulated by the androgen receptor in male mice.‏ ‎‡9 1‏
919 ‎‡a metabolismofvitamind3inhumanosteoblastsevidenceforautocrineandparacrineactivitiesof1alpha25dihydroxyvitamind3‏ ‎‡A Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3.‏ ‎‡9 1‏
919 ‎‡a mechanismsofvitamind3metaboliterepressionofigedependentmastcellactivation‏ ‎‡A Mechanisms of vitamin D₃ metabolite repression of IgE-dependent mast cell activation‏ ‎‡9 1‏
919 ‎‡a identificationofvitamind3targetgenesinhumanbreastcancertissue‏ ‎‡A Identification of vitamin D3 target genes in human breast cancer tissue.‏ ‎‡9 1‏
919 ‎‡a identificationofgrowthfactorindependent1gfi1asarepressorof25hydroxyvitamin5001alphahydroxylasecyp27b1geneexpressioninhumanprostatecancercells‏ ‎‡A Identification of growth factor independent-1 (GFI1) as a repressor of 25-hydroxyvitamin D 1-alpha hydroxylase (CYP27B1) gene expression in human prostate cancer cells‏ ‎‡9 1‏
919 ‎‡a extracellularphosphatemodulatestheeffectof1α25dihydroxyvitamind3125donosteocytelikecells‏ ‎‡A Extracellular phosphate modulates the effect of 1α,25-dihydroxy vitamin D3 (1,25D) on osteocyte like cells‏ ‎‡9 1‏
919 ‎‡a experimentalevidencefortheeffectsofcalciumandvitamin500onboneareview‏ ‎‡A Experimental evidence for the effects of calcium and vitamin D on bone: a review.‏ ‎‡9 1‏
919 ‎‡a evidenceforalteredosteoclastogenesisinsplenocyteculturesfromcyp27b1knockoutmice‏ ‎‡A Evidence for altered osteoclastogenesis in splenocyte cultures from Cyp27b1 knockout mice‏ ‎‡9 1‏
919 ‎‡a efficacyandmechanismsofactionofvitamin500inexperimentalpolyarthritis‏ ‎‡A Efficacy and mechanisms of action of vitamin D in experimental polyarthritis.‏ ‎‡9 1‏
919 ‎‡a earlyresponseofthehumansostgenetostimulationby1α25dihydroxyvitamind3‏ ‎‡A Early response of the human SOST gene to stimulation by 1α,25-dihydroxyvitamin D3.‏ ‎‡9 1‏
919 ‎‡a discordanteffectsofvitamin500deficiencyintrabecularandcorticalbonearchitectureandstrengthingrowingrodents‏ ‎‡A Discordant effects of vitamin D deficiency in trabecular and cortical bone architecture and strength in growing rodents.‏ ‎‡9 1‏
919 ‎‡a determinantsofcirculating125dihydroxyvitamind3levelstheroleofrenalsynthesisandcatabolismofvitamin500‏ ‎‡A Determinants of circulating 1,25-dihydroxyvitamin D3 levels: the role of renal synthesis and catabolism of vitamin D.‏ ‎‡9 1‏
919 ‎‡a coexpressionofcyp27b1enzymewiththe15kbcyp27b1promoterluciferasetransgeneinthemouse‏ ‎‡A Co-expression of CYP27B1 enzyme with the 1.5kb CYP27B1 promoter-luciferase transgene in the mouse‏ ‎‡9 1‏
919 ‎‡a calcitoninreceptorplaysaphysiologicalroletoprotectagainsthypercalcemiainmice‏ ‎‡A Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice‏ ‎‡9 1‏
919 ‎‡a bonecyp27b1geneexpressionisincreasedwithhighdietarycalciumandinmineralisingosteoblasts‏ ‎‡A Bone CYP27B1 gene expression is increased with high dietary calcium and in mineralising osteoblasts.‏ ‎‡9 1‏
919 ‎‡a androgenreceptoractioninosteoblastsinmalemiceisdependentontheirstageofmaturation‏ ‎‡A Androgen Receptor Action in Osteoblasts in Male Mice Is Dependent on Their Stage of Maturation‏ ‎‡9 1‏
919 ‎‡a analysisofvitamin500metabolismgeneexpressioninhumanboneevidenceforautocrinecontrolofboneremodelling‏ ‎‡A Analysis of vitamin D metabolism gene expression in human bone: evidence for autocrine control of bone remodelling‏ ‎‡9 1‏
919 ‎‡a adequatedietaryvitamin500andcalciumarebothrequiredtoreduceboneturnoverandincreasedbonemineralvolume‏ ‎‡A Adequate dietary vitamin D and calcium are both required to reduce bone turnover and increased bone mineral volume‏ ‎‡9 1‏
919 ‎‡a roleforthecalcitoninreceptortolimitbonelossduringlactationinfemalemicebyinhibitingosteocyticosteolysis‏ ‎‡A A Role for the Calcitonin Receptor to Limit Bone Loss During Lactation in Female Mice by Inhibiting Osteocytic Osteolysis.‏ ‎‡9 1‏
919 ‎‡a 25hydroxyvitamin500requirementformaintainingskeletalhealthutilisingaspraguedawleyratmodel‏ ‎‡A 25-Hydroxyvitamin D requirement for maintaining skeletal health utilising a Sprague-Dawley rat model‏ ‎‡9 1‏
919 ‎‡a 1α25dihydroxyvitamind3stimulateshumansostgeneexpressionandsclerostinsecretion‏ ‎‡A 1α,25-dihydroxyvitamin D3 stimulates human SOST gene expression and sclerostin secretion‏ ‎‡9 1‏
919 ‎‡a 125dihydroxyvitamind3andextracellularcalciumpromotemineraldepositionvianpp1activityinamatureosteoblastcelllinemloa5‏ ‎‡A 1,25-Dihydroxyvitamin D3 and extracellular calcium promote mineral deposition via NPP1 activity in a mature osteoblast cell line MLO-A5.‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 NTA|075077957‏
996 ‎‡2 ISNI|0000000052328674‏
996 ‎‡2 RERO|A012332919‏
996 ‎‡2 J9U|987007419252905171‏
996 ‎‡2 SUDOC|061285919‏
996 ‎‡2 LC|n 86851450‏
996 ‎‡2 DNB|1093227907‏
996 ‎‡2 LC|nb2020001392‏
996 ‎‡2 BIBSYS|90540128‏
996 ‎‡2 NUKAT|n 2019012664‏
996 ‎‡2 ISNI|0000000083570818‏
996 ‎‡2 DNB|1103840894‏
996 ‎‡2 ISNI|0000000079620448‏
996 ‎‡2 LC|n 92803137‏
996 ‎‡2 J9U|987007454425805171‏
996 ‎‡2 ISNI|0000000076379927‏
996 ‎‡2 J9U|987008729600305171‏
996 ‎‡2 ISNI|0000000029435236‏
996 ‎‡2 BIBSYS|90567746‏
996 ‎‡2 BIBSYS|8023717‏
996 ‎‡2 J9U|987007357694905171‏
996 ‎‡2 RERO|A011531297‏
996 ‎‡2 LC|no2021120529‏
996 ‎‡2 LC|n 2001063550‏
996 ‎‡2 RERO|A025076487‏
996 ‎‡2 LIH|LNB:CMJ_u_;=B_l_‏
996 ‎‡2 J9U|987007435916505171‏
996 ‎‡2 ISNI|0000000059605048‏
996 ‎‡2 ISNI|000000002313802X‏
996 ‎‡2 J9U|987007332918805171‏
996 ‎‡2 NKC|mub2012690428‏
996 ‎‡2 SIMACOB|58662243‏
996 ‎‡2 DNB|1022731726‏
996 ‎‡2 ISNI|0000000109083779‏
996 ‎‡2 LC|n 85031283‏
996 ‎‡2 NLA|000035168971‏
996 ‎‡2 SUDOC|263280578‏
996 ‎‡2 NDL|00807002‏
996 ‎‡2 CAOONL|ncf10546165‏
996 ‎‡2 ISNI|0000000420541103‏
996 ‎‡2 SUDOC|232686246‏
996 ‎‡2 ISNI|0000000054970855‏
996 ‎‡2 ISNI|0000000384950590‏
996 ‎‡2 LC|n 85214702‏
996 ‎‡2 LC|nb2012009014‏
996 ‎‡2 DNB|1218113626‏
996 ‎‡2 NLA|000035699691‏
996 ‎‡2 LC|n 87859814‏
996 ‎‡2 PLWABN|9810562274005606‏
996 ‎‡2 LC|n 79002456‏
996 ‎‡2 DNB|102719110X‏
996 ‎‡2 ISNI|0000000367349242‏
996 ‎‡2 LC|no2015105340‏
996 ‎‡2 LC|n 96081398‏
996 ‎‡2 DNB|1075015987‏
996 ‎‡2 ISNI|0000000034323861‏
996 ‎‡2 BIBSYS|11033536‏
996 ‎‡2 DNB|1055318887‏
996 ‎‡2 BNF|18031977‏
996 ‎‡2 ISNI|0000000374020496‏
996 ‎‡2 LNB|LNC10-000038179‏
996 ‎‡2 ISNI|0000000074207849‏
996 ‎‡2 BNE|XX1001478‏
996 ‎‡2 ISNI|0000000029242629‏
996 ‎‡2 NII|DA03153096‏
996 ‎‡2 ISNI|0000000043449423‏
996 ‎‡2 J9U|987007570064505171‏
996 ‎‡2 SUDOC|196232767‏
996 ‎‡2 BNF|14487936‏
996 ‎‡2 J9U|987007352336505171‏
996 ‎‡2 NKC|pna2006327202‏
996 ‎‡2 ISNI|0000000108999259‏
996 ‎‡2 DBC|87097969365019‏
996 ‎‡2 RERO|A025644255‏
996 ‎‡2 CAOONL|ncf10167277‏
996 ‎‡2 LC|no2014006950‏
996 ‎‡2 ISNI|0000000110810072‏
996 ‎‡2 LC|no2018146264‏
996 ‎‡2 SUDOC|035803320‏
996 ‎‡2 J9U|987007320865005171‏
996 ‎‡2 NTA|106860801‏
996 ‎‡2 ISNI|0000000137374434‏
996 ‎‡2 NII|DA04838668‏
996 ‎‡2 DNB|1193216265‏
996 ‎‡2 PTBNP|4661‏
996 ‎‡2 ISNI|0000000030371663‏
996 ‎‡2 LC|no2016024883‏
996 ‎‡2 DNB|1235171752‏
996 ‎‡2 LC|no2006015149‏
996 ‎‡2 ISNI|0000000053165010‏
996 ‎‡2 DBC|87097969364993‏
996 ‎‡2 LC|no2004052627‏
996 ‎‡2 PLWABN|9810715593205606‏
996 ‎‡2 BNF|12530794‏
996 ‎‡2 N6I|vtls002139625‏
996 ‎‡2 N6I|vtls001347198‏
996 ‎‡2 BIBSYS|90280864‏
996 ‎‡2 NUKAT|n 2006092634‏
996 ‎‡2 ISNI|000000000025735X‏
996 ‎‡2 ISNI|0000000082766894‏
996 ‎‡2 BIBSYS|14059683‏
996 ‎‡2 LC|n 98059518‏
996 ‎‡2 J9U|987007427733405171‏
996 ‎‡2 ISNI|0000000031164033‏
996 ‎‡2 CAOONL|ncf11364454‏
996 ‎‡2 NYNYRILM|78760‏
996 ‎‡2 RERO|A002928477‏
996 ‎‡2 ISNI|0000000033428688‏
996 ‎‡2 BIBSYS|13063767‏
996 ‎‡2 RERO|A002928479‏
996 ‎‡2 RERO|A002928478‏
996 ‎‡2 BIBSYS|99042309‏
996 ‎‡2 SUDOC|145508161‏
996 ‎‡2 LC|no2022048281‏
996 ‎‡2 ISNI|0000000065778105‏
996 ‎‡2 RERO|A006413686‏
996 ‎‡2 LC|n 83161704‏
996 ‎‡2 SUDOC|111998700‏
996 ‎‡2 NUKAT|n 2014047924‏
996 ‎‡2 LC|nb2021012242‏
996 ‎‡2 CAOONL|ncf11275754‏
996 ‎‡2 ISNI|0000000044835553‏
996 ‎‡2 DNB|1288601212‏
996 ‎‡2 ISNI|0000000121433583‏
996 ‎‡2 LC|n 2012026024‏
996 ‎‡2 BNE|XX878707‏
996 ‎‡2 LC|nr2003026989‏
996 ‎‡2 ISNI|0000000045851192‏
996 ‎‡2 DNB|13182967X‏
996 ‎‡2 NII|DA0129436X‏
996 ‎‡2 DNB|1026378524‏
996 ‎‡2 DNB|138194025‏
996 ‎‡2 ISNI|0000000081930461‏
996 ‎‡2 LC|n 85085013‏
996 ‎‡2 BIBSYS|5019661‏
996 ‎‡2 ISNI|0000000114935841‏
996 ‎‡2 LC|no2009120412‏
996 ‎‡2 ISNI|0000000079084980‏
996 ‎‡2 ISNI|0000000084769255‏
996 ‎‡2 NTA|190076038‏
996 ‎‡2 J9U|987007277718205171‏
996 ‎‡2 J9U|987007340375005171‏
996 ‎‡2 LC|n 88037134‏
996 ‎‡2 BLBNB|000397790‏
996 ‎‡2 RERO|A002928480‏
996 ‎‡2 LC|n 83027571‏
996 ‎‡2 RERO|A002928483‏
996 ‎‡2 ISNI|0000000383850926‏
996 ‎‡2 NTA|314278745‏
996 ‎‡2 LC|n 83163844‏
996 ‎‡2 CAOONL|ncf11271121‏
996 ‎‡2 LC|n 88670631‏
996 ‎‡2 LC|no2008019729‏
996 ‎‡2 DNB|1036098850‏
996 ‎‡2 SUDOC|034164839‏
996 ‎‡2 SUDOC|242503691‏
996 ‎‡2 DNB|129529478‏
996 ‎‡2 ISNI|0000000021459137‏
996 ‎‡2 ISNI|0000000031129764‏
996 ‎‡2 BIBSYS|90402838‏
996 ‎‡2 LC|n 97007792‏
996 ‎‡2 NKC|jx20110428001‏
996 ‎‡2 LC|n 88613440‏
996 ‎‡2 LC|n 2002021649‏
996 ‎‡2 BLBNB|000988261‏
996 ‎‡2 J9U|987007423980605171‏
996 ‎‡2 LC|no 97031559‏
996 ‎‡2 ISNI|0000000031072411‏
996 ‎‡2 ISNI|0000000116329132‏
996 ‎‡2 LC|n 94013119‏
996 ‎‡2 NII|DA08579765‏
996 ‎‡2 LC|no2007138030‏
996 ‎‡2 NTA|074130730‏
996 ‎‡2 DNB|1021380059‏
996 ‎‡2 DNB|1157639291‏
996 ‎‡2 BNF|14513099‏
996 ‎‡2 SUDOC|09218118X‏
996 ‎‡2 BIBSYS|1634286305615‏
996 ‎‡2 ISNI|0000000430443056‏
996 ‎‡2 LC|nb2001076791‏
996 ‎‡2 NTA|069834288‏
996 ‎‡2 ISNI|0000000117044702‏
996 ‎‡2 ISNI|0000000123303221‏
996 ‎‡2 LC|n 90646764‏
996 ‎‡2 ISNI|0000000110814655‏
996 ‎‡2 LC|no2020093106‏
996 ‎‡2 LC|n 93802949‏
996 ‎‡2 LC|nb2012014506‏
996 ‎‡2 NLA|000035006637‏
996 ‎‡2 NLA|000035006639‏
996 ‎‡2 J9U|987007273721405171‏
996 ‎‡2 CAOONL|ncf11548405‏
996 ‎‡2 LIH|LNB:W_z_Z;=CB‏
996 ‎‡2 NLA|000035265899‏
996 ‎‡2 ISNI|0000000384247387‏
996 ‎‡2 LC|n 2001120419‏
996 ‎‡2 SUDOC|272922471‏
996 ‎‡2 SUDOC|145639673‏
996 ‎‡2 NKC|xx0043025‏
996 ‎‡2 LC|nb2002020170‏
996 ‎‡2 LC|n 85272615‏
996 ‎‡2 NSK|000043245‏
996 ‎‡2 ISNI|0000000139632484‏
996 ‎‡2 ISNI|0000000384504435‏
996 ‎‡2 LC|n 50021948‏
996 ‎‡2 LC|n 50021947‏
996 ‎‡2 SUDOC|079987923‏
996 ‎‡2 DNB|123567327‏
996 ‎‡2 ISNI|0000000079005496‏
996 ‎‡2 ISNI|0000000076809456‏
996 ‎‡2 NUKAT|n 2008123798‏
996 ‎‡2 LC|n 90625187‏
996 ‎‡2 BLBNB|000598448‏
996 ‎‡2 RERO|A012426822‏
996 ‎‡2 J9U|987007438003205171‏
996 ‎‡2 ISNI|0000000101813589‏
996 ‎‡2 J9U|987007320796805171‏
996 ‎‡2 LC|n 50051908‏
996 ‎‡2 BLBNB|000598445‏
996 ‎‡2 LC|nb 98039719‏
996 ‎‡2 DBC|87097969365000‏
996 ‎‡2 LC|n 85814310‏
996 ‎‡2 LC|n 2004065587‏
996 ‎‡2 LC|nb2011018883‏
996 ‎‡2 BNF|14553347‏
996 ‎‡2 JPG|500065743‏
996 ‎‡2 NUKAT|n 2003037229‏
996 ‎‡2 ISNI|0000000037724898‏
996 ‎‡2 LC|n 79140996‏
996 ‎‡2 NSK|000381879‏
996 ‎‡2 SUDOC|124624936‏
996 ‎‡2 PLWABN|9810544234905606‏
996 ‎‡2 ISNI|0000000039432506‏
996 ‎‡2 NKC|uk2015854708‏
996 ‎‡2 LC|n 78006194‏
996 ‎‡2 LC|n 2024010137‏
996 ‎‡2 ISNI|0000000509773656‏
996 ‎‡2 BIBSYS|11049785‏
996 ‎‡2 CAOONL|ncf11572266‏
996 ‎‡2 CAOONL|ncf11567831‏
996 ‎‡2 LC|n 80130721‏
996 ‎‡2 BIBSYS|90529301‏
996 ‎‡2 CAOONL|ncf11282688‏
996 ‎‡2 NII|DA09069855‏
996 ‎‡2 J9U|987007460314505171‏
996 ‎‡2 LC|no2014152387‏
996 ‎‡2 RERO|A002928041‏
996 ‎‡2 DNB|136315704‏
996 ‎‡2 LC|nb2023013454‏
996 ‎‡2 NKC|jn20000600206‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏